Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China flag China · Delayed Price · Currency is CNY
17.00
+1.07 (6.72%)
Sep 14, 2026, 3:00 PM CST

SHA:605369 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,1261,1161,100955.611,4591,188
Other Revenue
40.7219.9615.0219.479.255.85
1,1671,1361,115975.081,4691,194
Revenue Growth
4.33%1.84%14.37%-33.61%22.98%43.95%
Cost of Revenue
857.42830.4752.09661.42894.14668.83
Gross Profit
309.38305.3363.12313.66574.54525.42
Selling, General & Admin
142.93148.91141.21148.2162.48120.43
Research & Development
45.4845.653.0547.8172.3558.29
Other Operating Expenses
11.3910.1310.178.5112.897.71
Operating Expenses
202.5208.06208.95204.17250.32189.4
Operating Income
106.8897.24154.18109.49324.22336.02
Interest Expense
-5.15-5.65-2.87-1.45-0.04-0.03
Interest & Investment Income
20.0517.8430.9917.6715.0120.63
Currency Exchange Gain (Loss)
-23.34-8.785.97-5.3929.65-5.45
Other Non Operating Income (Expenses)
-0.39-0.38-0.28-0.23-0.41-1.53
EBT Excluding Unusual Items
98.05100.26187.98120.09368.43349.64
Impairment of Goodwill
-26.18-25.8-1.24-0.91--
Gain (Loss) on Sale of Investments
-1.93-10.164.07--1.83-
Gain (Loss) on Sale of Assets
-0.4-0.05-0.02-0.01-0.19.19
Asset Writedown
-0.33-0.35--1.69-1.48-2.29
Other Unusual Items
-1.33-1.06-2.061.745.664.2
Pretax Income
67.8762.83188.74119.23370.67360.73
Income Tax Expense
12.2511.4617.2310.144.6349.74
Earnings From Continuing Operations
55.6251.38171.5109.13326.04310.99
Minority Interest in Earnings
0.230.130.13---
Net Income
55.8551.51171.63109.13326.04310.99
Net Income to Common
55.8551.51171.63109.13326.04310.99
Net Income Growth
-55.92%-69.99%57.28%-66.53%4.84%37.68%
Shares Outstanding (Basic)
224224220221220220
Shares Outstanding (Diluted)
224224220221220220
Shares Change
2.37%1.77%-0.61%0.82%-0.20%23.76%
EPS (Basic)
0.250.230.780.491.481.41
EPS (Diluted)
0.250.230.780.491.481.41
EPS Growth
-56.94%-70.51%58.25%-66.80%5.05%11.25%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
162.38142.35100.7763.57110.5797.43
Free Cash Flow Per Share
0.720.640.460.290.500.44
Dividend Per Share
0.1500.1500.5000.4080.1530.704
Dividend Growth
-47.50%-70.00%22.49%166.62%-78.26%7.33%
Gross Margin
26.52%26.88%32.56%32.17%39.12%44.00%
Operating Margin
9.16%8.56%13.83%11.23%22.07%28.14%
Profit Margin
4.79%4.54%15.39%11.19%22.20%26.04%
Free Cash Flow Margin
13.92%12.53%9.04%6.52%7.53%8.16%
EBITDA
193.19184.45247.79193.48364.88357.54
EBITDA Margin
16.56%16.24%22.22%19.84%24.84%29.94%
D&A For EBITDA
86.3187.2193.6283.9940.6621.52
EBIT
106.8897.24154.18109.49324.22336.02
EBIT Margin
9.16%8.56%13.83%11.23%22.07%28.14%
Effective Tax Rate
18.05%18.23%9.13%8.47%12.04%13.79%
Revenue as Reported
1,1671,1361,115975.081,4691,194
Advertising Expenses
-5.64.364.173.5624.14